retatrutide triple hormone receptor agonist obesity 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase 3 Trial New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide Dosage & Titration: Complete

Apps that help you stay on top of injections, protein, training and mindset are not nice-to-haves on a GLP-1 journey

Chicken, fish, eggs, Greek yogurt, tofu, legumeswhatever your preference

Both basic research and clinical studies have suggested that GLP-1 receptor agonists may have the potential to improve stroke recurrence and prognosis. LAMP was a multicenter, randomized controlled, prospective trial designed to evaluate the efficacy and safety of liraglutide (Victoza/Saxenda, Novo Nordisk) for the prevention of recurrent stroke after minor ischemic stroke or high-risk TIA in patients with diabetes

Alcohol use disorder trials

Understanding what is normal versus what warrants medical attention helps you stay safe during treatment